Molecular and Cellular Mechanisms in Photomedicine: Porphyrins in Cancer Treatment

作者: Giulio Jori , Ivo Cozzani , Maria F. Vigna , Antonio Tau , T. M. A. R. Dubbelman

DOI: 10.1007/978-1-4684-1224-6_20

关键词:

摘要: The use of visible light in combination with a photosensitizing dye for the treatment various types tumors has been repeatedly attempted since early 1900s when topically applied eosin and sunlight were shown to induce regression skin tumors1. This approach appears be particularly attractive i) several photosensitizers polycyclic chemical structure, including xanthenes2, acridines3, psoralens4, display preferential affinity neoplastic as compared normal cells; ii) most cell constituents, particular proteins nucleic acids, are insensitive direct action light. In principle, these two properties should allow one restrict photodynamic effects causing inactivation necrosis dye-loaded tissue, no concomitant damage dye-free tissues, provided suitable set wavelengths is selected irradiation. Thus, therapy exhibits potential advantage respect other therapeutic modalities which based on ionizing radiations; latter cases, simultaneous irreversible tissues often limits extent efficacy treatment. Toward this aim, an ideal photosensitizer have following properties: lack systemic toxicity; selective uptake retention by malignant tissues; iii) absorption incident light; iv) efficient generation photoreactive species leading destruction tissues.

参考文章(88)
Charles J Gomer, Bernard C Szirth, Daniel R Doiron, James V Jester, Robert W Lingua, Corey Mark, William F Benedict, A Linn Murphree, None, Preclinical Evaluation of Hematoporphyrin Derivative for the Treatment of Intraocular Tumors: A Preliminary Report Advances in Experimental Medicine and Biology. ,vol. 160, pp. 109- 114 ,(1983) , 10.1007/978-1-4684-4406-3_11
Joon E. Roberts, The photodynamic effect of chlorpromazine, promazine, and hematoporphyrin on lens protein. Investigative Ophthalmology & Visual Science. ,vol. 25, pp. 746- 750 ,(1984)
T. J. Dougherty, W. R. Potter, K. R. Weishaupt, The Structure of the Active Component of Hematoporphyrin Derivative Porphyrins in Tumor Phototherapy. ,vol. 170, pp. 23- 35 ,(1984) , 10.1007/978-1-4684-4721-7_3
Shigeru Okuda, Seishiro Mimura, Toru Otani, Makoto Ichii, Masaharu Tatsuta, Experimental and Clinical Studies on HPD-Photoradiation Therapy for Upper Gastrointestinal Cancer Porphyrins in Tumor Phototherapy. pp. 413- 421 ,(1984) , 10.1007/978-1-4684-4721-7_45
I. Cozzani, G. Jori, E. Reddi, L. Tomio, P. L. Zorat, T. Sicuro, G. Malvaldi, Interaction of Free and Liposome-Bound Porphyrins with Normal and Malignant Cells: Biochemical and Photosensitization Studies in Vitro and in Vivo Porphyrins in Tumor Phototherapy. pp. 157- 165 ,(1984) , 10.1007/978-1-4684-4721-7_17
R. S. Bush, F. A. Beale, A. J. Dembo, W. E. Allt, H. Bean, J. F. Pringle, R. D. Jenkin, Definitive evidence for hypoxic cells influencing cure in cancer therapy. The British journal of cancer. Supplement. ,vol. 3, pp. 302- 306 ,(1978)
Thierry Patrice, Marie-Françoise Le Bodic, Christos Roussakis, Yves Le Tourneux, Louis Le Bodic, Nd Yag Destruction of Tumor Sensitized or Non Sensitized by HPD Porphyrins in Tumor Phototherapy. pp. 247- 249 ,(1984) , 10.1007/978-1-4684-4721-7_28
P. L. Zorat, L. Tomio, L. Corti, F. Calzavara, G. Sotti, G. Jori, E. Reddi, G. Mandoliti, Hematoporphyrin Phototherapy of Malignant Tumors Porphyrins in Tumor Phototherapy. pp. 381- 387 ,(1984) , 10.1007/978-1-4684-4721-7_41